List of Studies ( Metabolite:8-Aminooctanoic acid)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000421 | AN000665 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST001683 | AN002749 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Blood | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002749 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Feces | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002749 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Intestine | Mouse | Stanford University | Raw ion count (peak area) | |
ST001683 | AN002749 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Urine | Mouse | Stanford University | Raw ion count (peak area) | |
ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |